“Computational Study of 1-(3-Nitrobenzoyloxymethyl)-5-Fluorouracyl Derivatives as Colorectal Cancer Agents”, Valensi, vol. 8, no. 2, pp. 211–220, Nov. 2022, doi: 10.15408/jkv.v8i2.25489.